AMR is threatening human and animal health as well as the environment. The consequences of inaction are too grave to contemplate.
About the AMR Stakeholder Network
EPHA joins call on the European Commission for immediate action on the threats from pharmaceutical pollution
5 concrete measures for the European Commission to take immediately to protect public and environmental health.read more
Ambition versus compromise: is the European Union’s Strategic Approach to Pharmaceuticals in the Environment robust enough?
The Commission’s Strategic Approach ignores existing evidence and continues to postpone action.read more
EPHA co-signs response to the public consultation on draft recommendations of the Inter-Agency Coordination Group on AMR
An urgent response to the challenge of AMR, increased investment, measurable targets and accountability mechanisms are needed.read more
Analysis & Opinion
The new UK national action plan on AMR takes things further by offering a “fully integrated and aligned” One Health approach covering health, animals, the environment and the food chain.read more
Tackling pharmaceutical pollution in the environment is crucial is we are to tackle the threat of antimicrobial resistanceread more
Invest and Protect7 May 2019
Sustainable financing to tackle AMR. What can the EU do to support Member States’ efforts to tackle AMR nationally, regionally and locally?
Do you have a question?
Meet our AMR Policy Leads and Scientific Advisors.
+32 (0) 2 233 3877
Rose Gallagher MBE
EPHA Scientific Advisor on AMR
Professional Lead Infection Prevention & Control, Royal College of Nursing (UK)